Showing results (251-260 of 403) with videos related to
Sort By:
Pageof 41
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urineN Kurata, T Kuramitsu, H Tanii, et al.Journal of the Neurological Sciences|April 1, 1987
A mitochondrial encephalomyopathy with cardiomyopathy. A case revealing a defect of complex I in the respiratory chainM Nishizawa, K Tanaka, K Shinozawa, et al.Pharmaceutical Research|July 11, 2000
Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01 from human alpha1-acid glycoproteinE Fuse, A Hashimoto, N Sato, et al.Cellular Immunology|April 1, 1988
Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU)M K Kim, R R Caspi, R B Nussenblatt, et al.British Journal of Cancer|August 14, 1998
Interleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogueN Masuda, S Negoro, K Takeda, et al.American Journal of Ophthalmology|September 1, 1976
Adrenoleukodystrophy with disease of the eye and optic nerveS H Wray, D G Cogan, T Kuwabara, et al.FEBS Letters|May 10, 2000
Significant change in the structure of a ribozyme upon introduction of a phosphorothioate linkage at P9: NMR reveals a conformational fluctuation in the core region of a hammerhead ribozymeK Suzumura, M Warashina, K Yoshinari, et al.Nucleic Acids Symposium Series|April 26, 2000
Action of metal ions directly involved in the cleavage reaction of hammerhead ribozymesY Nakamatsu, M Warashina, T Kuwabara, et al.No Shinkei Geka. Neurological Surgery|January 1, 1984
[Chemotherapy for experimental subarachnoid dissemination model of brain tumor]T Yamashita, M Shinonaga, Y Ishiwata, et al.Nucleic Acids Research|July 4, 2001
Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cellsT Kuwabara, M Warashina, S Koseki, et al.Pageof 41